Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Polyrizon Ltd. ( (PLRZ) ) has issued an update.
On April 8, 2025, Polyrizon Ltd. received a notification from Nasdaq indicating non-compliance with the minimum bid price requirement, as their stock price had been below $1.00 for 30 consecutive business days. The company has until October 6, 2025, to regain compliance, during which time their shares will continue to be listed. If compliance is not achieved, they may receive an additional 180-day period to meet the requirements, failing which their shares could be delisted. Polyrizon is actively monitoring the situation and considering options to address the issue.
More about Polyrizon Ltd.
Polyrizon Ltd. is a development stage biotech company that specializes in innovative intranasal hydrogels. Their primary product is a nasal spray that forms a hydrogel-based shield to protect against viruses and allergens. The company is also working on technologies for the nasal delivery of active pharmaceutical ingredients.
YTD Price Performance: -80.27%
Average Trading Volume: 320,090
Technical Sentiment Signal: Strong Buy
See more data about PLRZ stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “More Hopeful than Real”: Is a Bidding War Brewing for Warner Bros. Discovery Stock (NASDAQ:WBD)?
- “Didn’t Develop the Way Automakers Thought.” Ford Notches Up, Reconsidering the EV Market
- “Our Focus is Increasingly…on Inference”: Intel Stock (NASDAQ:INTC) Jumps With Crescent Island Testing Next Year